Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Methods Collections

Transcatheter therapies for structural heart diseases

COVID-19 response: Video production in affected areas is postponed, publishing text articles first

JoVE will publish text articles after the peer review, which on average takes two months after the manuscript submission. We will film and add corresponding videos to our website when laboratories and facilities in affected areas reopen.

Just Started
Methods Collection Image
Methods Collections
Transcatheter therapies for structural heart diseases

Guest Editors
Alexander Lauten

Department of General and Interventional Cardiology

Prof. Dr. med Alexander Lauten is Head of the Department of General and Interventional Cardiology at Helios Klinikum...

Brunilda Alushi

Department of Cardiology

Dr. Brunilda Alushi is an MD and a PhD in Molecular Medicine, from the University of Turin, Italy, and specialist in...

Collection Overview

The incidence of valvular heart diseases, which are responsible for a high rate of morbidity and mortality worldwide, increases with age. Until recently, the only treatment option was surgery. With the advent of transcatheter solutions, a result of impressive technical developments in the field of medical devices, the landscape of treatment strategies for patients with valvular heart diseases has dramatically improved. Today, numerous available devices offer percutaneous treatment options for these severe conditions while avoiding surgery. Whereas the transcatheter aortic valve replacement (TAVR/TAVI) is a well-established technique, now expanding to low risk patients, interventional treatment of mitral and tricuspid valve pathologies is more complex and requires a patient-tailored approach, strongly based on multimodality imaging techniques like two -and three-dimensional echocardiography, cardiac computed tomography, and MRI.

In this collection, we will focus on recent developments in the field of interventional treatment solutions for patients with valvular heart diseases, while discussing the technical aspects and challenges related to patient and device selection, especially for mitral and tricuspid valve pathologies.

 

Abstracts

Edge To Edge Tricuspid Valve Repair Using the Modified Steering of the Mitraclip System

Osama Bisht*1, Brunilda Alushi1, Philipp Lurz2, Jörg Hausleiter3, Hani Mahmoud-Elsayed4, Alexander Lauten1
1Helios Klinikum Erfurt, 2Herzzentrum Leipzig, 3Ludwig-Maximillians University, Munich, 4Queen Elisabeth Hospital, Brimingham

Isolation and culture of T lymphocytes from stenotic aortic valves using feeder cells from irradiated buffy coat.

Lavinia Curini*1, Mary Roxana Christopher2, Brunilda Alushi 3, Herko Grubitzsch4, Ulf Landmesser5, Amedeo Amedei6, Alexander Lauten 3
1Department of Cardiology, Charite´ Universitätsmedizin Berlin and German Centre for Cardiovascular Research (DZHK), Berlin, Germany; Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy, 2Department of Cardiology, Charite´ Universitätsmedizin Berlin and German Centre for Cardiovascular Research (DZHK), Berlin, Germany, 3Department of Cardiology, Charite´ Universitätsmedizin Berlin and German Centre for Cardiovascular Research (DZHK), Berlin, Germany; Department of General and Interventional Cardiology, Helios Klinikum Erfurt, Erfurt, Germany, 4Berlin Institute of Health, Berlin, Germany;Department of Cardiology, German Heart Centre Berlin (DHZB), Berlin, Germany, 5Department of Cardiology, Charite´ Universitätsmedizin Berlin and German Centre for Cardiovascular Research (DZHK), Berlin, Germany; Berlin Institute of Health, Berlin, Germany, 6Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; Sod of Interdisciplinary Internal Medicine, Azienda Ospedaliera Universitaria Careggi (AOUC), Florence, Italy

A simplified stepwise approach to echoguidance during the MitraClip procedure

Alessia Gatti*1
1Unfallkrankenhaus Berlin

Supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease: the LIRA method

Gianmarco Iannopollo*1
1Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy

Pushing the boundaries of TAVR to low risk young patients. How far are we?

Luigi Biasco*1
1Università della Svizzera Italiana

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
simple hit counter